A feasibility study of a personalised public mental health intervention for young women aged 14 to 18 years

My Story and Me: A feasibility study of a personalised public mental health intervention for young women 14 to 18 years

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN12191423

Enrollment

120

Registered

2025-05-22

Start date

2025-10-01

Completion date

Unknown

Last updated

2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Public mental health intervention for young women Mental and Behavioural Disorders

Interventions

The study builds on a 6-month Application Development Award, in which the public mental health intervention, ‘My Story and Me’ was developed comprising: 1) Watching a video of a young woman’s story, c

Eligibility

Sex/Gender

Female

Age

14 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Young women and girls (using an inclusive definition co-produced with young people) 2. Aged 14-18 years 3. No active suicidal ideation 4. Not currently seeking/receiving specialist mental health support 5. Able to provide consent, including parent/carer consent for <16s

Exclusion criteria

Exclusion criteria: 1. Outside age range 14-18 years 2. Active suicidal ideation 3. Currently seeking/receiving specialist mental health support 4. Not able to provide consent, including parent/carer consent for <16s

Design outcomes

Primary

Measure	Time frame
Depression and anxiety symptom scores measured using the 13-item Short Mood and Feelings Questionnaire (SMFQ) at baseline and 7-month follow-up	—

Secondary

Measure	Time frame
The following secondary outcome measures are assessed at baseline and 7-month follow-up, unless stated: Validated measures: 1. Anxiety will be measured using the Generalized Anxiety Disorder-7 (GAD-7) 2. Depression and anxiety will be measured using the 11-item RCADS 3. Social support will be measured using the 12-item Multidimensional Scale of Perceived Social Support (MSPSS) 4. Mentalising will be measured using the five-item Reflective Functioning Questionnaire Youth-5 5. Stigma will be measured using the 6-item Mental Health Knowledge Schedule 6. Quality of life will be measured using the six-item EQ-5D-5L and the nine-item CHU-9D Non-validated measures: 1. Loneliness measured using a single bespoke question 2. Mental health empowerment will be measured using the Mental Health Empowerment Scale, with four items 3. Intervention acceptability will be measured using the seven-item Theoretical Framework of Acceptability at follow-up 4. Resource use will be measured using an adapted version of the CA-SUS 5. Demographic questions will be collected on age, gender, sexual orientation, ethnicity, religion, special educational needs, disability, care experience, and caring responsibilities; postcode of residence will be collected and mapped onto national data for area-level indices of deprivation at baseline 6. Randomization acceptability will be measured using a single bespoke question item at baseline	—

Measure

Time frame

The following secondary outcome measures are assessed at baseline and 7-month follow-up, unless stated: Validated measures: 1. Anxiety will be measured using the Generalized Anxiety Disorder-7 (GAD-7) 2. Depression and anxiety will be measured using the 11-item RCADS 3. Social support will be measured using the 12-item Multidimensional Scale of Perceived Social Support (MSPSS) 4. Mentalising will be measured using the five-item Reflective Functioning Questionnaire Youth-5 5. Stigma will be measured using the 6-item Mental Health Knowledge Schedule 6. Quality of life will be measured using the six-item EQ-5D-5L and the nine-item CHU-9D Non-validated measures: 1. Loneliness measured using a single bespoke question 2. Mental health empowerment will be measured using the Mental Health Empowerment Scale, with four items 3. Intervention acceptability will be measured using the seven-item Theoretical Framework of Acceptability at follow-up 4. Resource use will be measured using an adapted version of the CA-SUS 5. Demographic questions will be collected on age, gender, sexual orientation, ethnicity, religion, special educational needs, disability, care experience, and caring responsibilities; postcode of residence will be collected and mapped onto national data for area-level indices of deprivation at baseline 6. Randomization acceptability will be measured using a single bespoke question item at baseline

—

Countries

England, United Kingdom

Contacts

Public ContactAngelika Labno

mystory@annafreud.org+44 (0)20 7794 2313

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Sep 19, 2026